The Era of Statins – Is There Still a Place for Other Classes of Lipid-Lowering Drugs?

Publisher： Karger

E-ISSN： 1424-0556|5|1|34-38

ISSN： 1422-9528

Source： Heart Drug, Vol.5, Iss.1, 2005-02, pp. : 34-38

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination lipid-lowering therapy with statins: safety issues in the postcerivastatin era

By Jacobson Terry A

Expert Opinion on Drug Safety, Vol. 2, Iss. 3, 2003-05 ,pp. : 269-286

Informa Healthcare

Access to resources Recommend Favorite

The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels

By Dierkes Jutta Westphal Sabine Luley Claus

Expert Opinion on Drug Safety, Vol. 3, Iss. 2, 2004-03 ,pp. : 101-111

Informa Healthcare

Access to resources Recommend Favorite

New prospects for lipid-lowering drugs

By Thompson G.R. Naoumova R.P.

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 5, 1998-05 ,pp. : 715-727

Informa Healthcare

Access to resources Recommend Favorite

Emerging lipid-lowering drugs: squalene synthase inhibitors

By Elsayed Raghda K Evans Jeffery D

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 2, 2008-06 ,pp. : 309-322

Informa Healthcare

Access to resources Recommend Favorite

Patients are less likely to receive lipid-lowering drugs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 371, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite